CEVA Shares STRUGGLE Thanks to Nokia and 4 More Analyst Alerts

MAKO Surgical Corp. (NASDAQ:MAKO): According to Piper Jaffray, free cash flow yield and historical valuation analysis of MAKO Surgical when compared to Intuitive Surgical (NASDAQ:ISRG) and other traditional medical device brands indicate a significant upside to MAKO’s shares. Piper continues to be a buyer of MAKO a current levels and maintains its Overweight rating with a $49 price target on the stock.

Don’t Miss: Apple and RIM Data Are at the Center of This Insider Trading Case.

inContact, Inc. (NASDAQ:SAAS): Benchmark Co. credits the recent pullback of inContact shares to the departure of it sales executive and a broad market downturn, but the firm believes that it creates a buying opportunity, and the firm maintains a Buy rating and a $7 price target on the stock.

CEVA Inc. (NASDAQ:CEVA): Although CEVA shares may continue to feel the weight of Nokia’s continuing market share loss, Benchmark Co. believes that the company’s long-term growth story is still unharmed. The firm sees this recent weakness in shares as a buying opportunity.

Healthcare Services Group Inc. (NASDAQ:HCSG): Benchmark Co. believes the company’s recent weakness in shares has created an entry point into the name. The firm reiterates its Buy rating with a $23.50 price target.

J. C. Penney Company, Inc. (NYSE:JCP): Following the departure of J.C. Penney President Michael Francis, Citigroup sees the company’s transformation staying on track. Stating that J.C. Penney possesses a strong bench of talent, Citi maintains a Buy rating and a $40 price target on shares.

Don’t Miss: Are J.C. Penney Investors Anxious for the Apple Turnaround Touch?

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.